What one share of Edwards Lifesciences holds
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence, and meaningful partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.
Edwards Lifesciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.20 |
|---|---|
| Profit | $1.73 |
| Capex (buildings and equipment) | $0.49 |
| Free cash flow | $2.47 |
| Cash and investments | $5.04 |
| Debt | $1.04 |
| Book value | $18.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $1.73 | $0.18 | $0.07 | $0.14 | — | $1.31 |
| 2009 | $1.87 | $0.33 | $0.09 | $0.14 | — | — |
| 2010 | $2.02 | $0.30 | $0.09 | $0.27 | — | $1.90 |
| 2011 | $2.34 | $0.33 | $0.11 | $0.32 | — | $1.94 |
| 2012 | $2.68 | $0.41 | $0.15 | $0.36 | — | $2.14 |
| 2013 | $3.00 | $0.57 | $0.16 | $0.53 | — | $2.35 |
| 2014 | $3.57 | $1.25 | $0.13 | $1.44 | — | — |
| 2015 | $3.77 | $0.75 | $0.16 | $0.68 | — | $3.87 |
| 2016 | $4.54 | $0.87 | $0.27 | $0.81 | — | $4.13 |
| 2017 | $5.30 | $0.90 | $0.26 | $1.29 | — | $4.70 |
| 2018 | $5.81 | $1.13 | $0.37 | $1.07 | — | $5.04 |
| 2019 | $6.83 | $1.64 | $0.40 | $1.46 | — | — |
| 2020 | $6.94 | $1.30 | $0.64 | $1.02 | — | $7.33 |
| 2021 | $8.29 | $2.38 | $0.52 | $2.23 | — | $9.35 |
| 2022 | $7.15 | $2.44 | $0.39 | $1.56 | — | $9.55 |
| 2023 | $8.22 | $2.30 | $0.42 | $1.05 | — | $11.06 |
| 2024 | $9.08 | $6.97 | $0.42 | $0.48 | — | $16.99 |
| 2025 | $10.36 | $1.83 | $0.44 | $2.28 | — | $17.80 |
Common questions about Edwards Lifesciences
How much does one share of Edwards Lifesciences earn?
Over the last 12 months, each share of Edwards Lifesciences earned $1.73 of profit on $11.20 of sales, keeping about 15¢ of every $1 (profit margin).
Does Edwards Lifesciences pay a dividend?
Edwards Lifesciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Edwards Lifesciences’s book value per share?
Edwards Lifesciences’s book value is $18.41 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Edwards Lifesciences have?
Each share of Edwards Lifesciences has $5.04 of cash and investments and $1.04 of debt, as of June 30, 2026.
What is Edwards Lifesciences’s free cash flow per share?
$2.47 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Edwards Lifesciences’s profit per share changed over time?
Profit per share went from $0.18 in 2008 to $1.83 in 2025, growing about 14.5% a year (adjusted for stock splits).
Has Edwards Lifesciences bought back shares?
Edwards Lifesciences’s share count fell about 18% from 2008 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.